Association of Sex Differences with Mortality and Organ Dysfunction in Patients with Sepsis and Septic Shock.
critical illness
organ dysfunction
sepsis
sepsis mortality
septic shock
sex
sex differences
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
15 May 2023
15 May 2023
Historique:
received:
17
04
2023
revised:
08
05
2023
accepted:
14
05
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
Despite recent advances in the clinical management and understanding of sepsis and septic shock, these complex clinical syndromes continue to have high mortality rates. The effect of sex on these diseases' mortality, clinical presentation and morbidity remains controversial. This study aimed to investigate the association of sex with mortality and organ dysfunction in patients with sepsis and septic shock. Prospectively enrolled patients with clinically defined sepsis and septic shock in three intensive care units at University Medical Center Göttingen, Germany, were investigated. The primary outcomes were 28- and 90-day mortality, while the secondary endpoints included the evaluation of organ dysfunction as measured by clinical scores and laboratory parameters. A total of 737 septic patients were enrolled, including 373 in septic shock, 484 males, and 253 females. No significant differences in 28- and 90-day mortality were observed in the cohort. However, men with sepsis had significantly higher SOFA scores, SOFA respiratory and renal subscores, bilirubin and creatinine values, and lower weight-adapted urine outputs, indicating higher organ dysfunction compared to women. Our findings revealed notable differences in organ dysfunction between male and female patients, with males exhibiting more pronounced dysfunction across multiple clinical indicators. These results highlight the potential influence of sex on sepsis disease severity and suggest the need for tailored approaches in sepsis management according to patient sex.
Sections du résumé
BACKGROUND
BACKGROUND
Despite recent advances in the clinical management and understanding of sepsis and septic shock, these complex clinical syndromes continue to have high mortality rates. The effect of sex on these diseases' mortality, clinical presentation and morbidity remains controversial. This study aimed to investigate the association of sex with mortality and organ dysfunction in patients with sepsis and septic shock.
METHODS
METHODS
Prospectively enrolled patients with clinically defined sepsis and septic shock in three intensive care units at University Medical Center Göttingen, Germany, were investigated. The primary outcomes were 28- and 90-day mortality, while the secondary endpoints included the evaluation of organ dysfunction as measured by clinical scores and laboratory parameters.
RESULTS
RESULTS
A total of 737 septic patients were enrolled, including 373 in septic shock, 484 males, and 253 females. No significant differences in 28- and 90-day mortality were observed in the cohort. However, men with sepsis had significantly higher SOFA scores, SOFA respiratory and renal subscores, bilirubin and creatinine values, and lower weight-adapted urine outputs, indicating higher organ dysfunction compared to women.
CONCLUSIONS
CONCLUSIONS
Our findings revealed notable differences in organ dysfunction between male and female patients, with males exhibiting more pronounced dysfunction across multiple clinical indicators. These results highlight the potential influence of sex on sepsis disease severity and suggest the need for tailored approaches in sepsis management according to patient sex.
Identifiants
pubmed: 37241006
pii: jpm13050836
doi: 10.3390/jpm13050836
pmc: PMC10221338
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Volkswagen Foundation
ID : ZN3168
Références
Crit Care Med. 2008 Jun;36(6):1838-45
pubmed: 18496363
Crit Care. 2013 Mar 18;17(2):R50
pubmed: 23506971
Int J Mol Sci. 2020 Nov 06;21(21):
pubmed: 33171904
J Clin Med. 2022 Nov 23;11(23):
pubmed: 36498479
Intensive Care Med. 2020 Aug;46(8):1536-1551
pubmed: 32591853
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
J Clin Med. 2019 Dec 24;9(1):
pubmed: 31878238
Chest. 2011 Nov;140(5):1223-1231
pubmed: 21852297
Sci Rep. 2018 Oct 11;8(1):15140
pubmed: 30310101
JAMA. 1999 Dec 8;282(22):2143-8
pubmed: 10591336
Crit Care Med. 2001 Jul;29(7):1303-10
pubmed: 11445675
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Virulence. 2014 Jan 1;5(1):12-9
pubmed: 24193307
Lancet Infect Dis. 2010 May;10(5):338-49
pubmed: 20417416
Crit Care Med. 2003 Apr;31(4):1250-6
pubmed: 12682500
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Chest. 2007 Dec;132(6):1786-93
pubmed: 17890473
J Clin Med. 2021 Nov 15;10(22):
pubmed: 34830585
Crit Care Med. 2013 May;41(5):1167-74
pubmed: 23442987
J Infect. 2022 Jun;84(6):770-776
pubmed: 35472366
Gend Med. 2010 Oct;7(5):422-37
pubmed: 21056869
Sci Rep. 2017 Aug 29;7(1):9887
pubmed: 28851893
Clin Sci (Lond). 2020 Jul 31;134(14):1887-1909
pubmed: 32662516
Am J Physiol Renal Physiol. 2012 Aug 1;303(3):F377-85
pubmed: 22622457
J Clin Med. 2022 Jun 28;11(13):
pubmed: 35807042
J Crit Care. 2014 Jun;29(3):473.e7-11
pubmed: 24559576
Microorganisms. 2023 Mar 14;11(3):
pubmed: 36985319
Shock. 2019 Aug;52(2):146-151
pubmed: 30138298
Crit Care Med. 2022 Jun 1;50(6):913-923
pubmed: 35148525
J Clin Med. 2019 Jan 10;8(1):
pubmed: 30634576
Front Immunol. 2022 Jul 14;13:895018
pubmed: 35911764
Crit Care Med. 2017 Nov;45(11):1854-1862
pubmed: 28806220
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2399-404
pubmed: 27363622
Cytokine. 2001 May 7;14(3):162-9
pubmed: 11396994
JAMA Netw Open. 2021 Nov 1;4(11):e2134290
pubmed: 34767025